Health-care providers' compliance with childhood acute lymphoblastic leukemia protocol in Indonesia

Mei Neni Sitaresmi1, Saskia Mostert, Chad M Gundy

  • 1Department of Growth and Development Pediatrics, Faculty of Medicine, Gadjah Mada University, Yogyakarta, Indonesia. msitaresmi@yahoo.com

Pediatric Blood & Cancer
|September 26, 2008
PubMed

Insights

Health-care providers in Indonesia often misclassify childhood acute lymphoblastic leukemia (ALL) risk, particularly missing key chemotherapy response indicators. Improving risk assessment is crucial for better treatment outcomes in pediatric leukemia patients.

Area of Science:

  • Pediatric Oncology
  • Hematology
  • Clinical Research

Background:

  • Protocol non-compliance significantly impacts childhood acute lymphoblastic leukemia (ALL) treatment outcomes.
  • Concerns regarding protocol adherence extend to parents, patients, and healthcare providers (HCP).
  • This study investigates leukemia risk classification accuracy and HCP attitudes toward protocol compliance in Indonesia.

Purpose of the Study:

  • To assess the accuracy of childhood acute lymphoblastic leukemia (ALL) risk classification in medical records.
  • To examine healthcare providers' knowledge of ALL risk classification criteria.
  • To evaluate healthcare providers' attitudes towards protocol compliance in pediatric leukemia care.

Main Methods:

  • A combined retrospective analysis of 164 medical records (MR) for ALL patients.
  • A cross-sectional questionnaire study involving 97 healthcare providers (HCP).
  • Assessment of ALL risk classification accuracy and HCP knowledge/attitudes regarding protocol adherence.

Main Results:

  • 50% of medical records lacked complete high-risk (HR) criteria for ALL.
  • 95% of HCP failed to recall all five HR criteria.
  • The lymphoblast count on day 8 of chemotherapy was the most frequently missed assessment criterion (35% of MR, 85% of questionnaires).
  • Only 14% of HCP verified medication administration with parents.

Conclusions:

  • Healthcare providers require enhanced knowledge and assessment skills for childhood ALL risk classification, especially regarding day 8 lymphoblast counts.
  • Accurate risk stratification and appropriate treatment are essential for improving cure rates in pediatric leukemia.
  • Addressing knowledge gaps in HCP is critical for optimizing childhood ALL management.
Abstract